| Name | [2-(3-morpholin-4-ylpropylamino)-3H-benzimidazol-5-yl]methanol |
|---|---|
| Synonyms |
(2-((3-morpholinopropyl)amino)-1H-benzo[d]imidazol-6-yl)methanol
[2-(3-morpholin-4-ylpropylamino)-3H-benzoimidazol-5-yl]methanol 1H-Benzimidazole-5-methanol,2-[[3-(4-morpholinyl)propyl]amino] |
| Molecular Formula | C15H22N4O2 |
|---|---|
| Molecular Weight | 290.36100 |
| Exact Mass | 290.17400 |
| PSA | 76.64000 |
| LogP | 0.54920 |
|
~84%
857070-67-8 |
| Literature: Bonfanti, Jean-Francois; Meyer, Christophe; Doublet, Frederic; Fortin, Jerome; Mueller, Philippe; Queguiner, Laurence; Gevers, Tom; Janssens, Peggy; Szel, Heidi; Willebrords, Rudy; Timmerman, Philip; Wuyts, Koen; Van Remoortere, Pieter; Janssens, Frans; Wigerinck, Piet; Andries, Koen Journal of Medicinal Chemistry, 2008 , vol. 51, # 4 p. 875 - 896 |
|
~81%
857070-67-8 |
| Literature: TIBOTEC PHARMACEUTICALS LTD. Patent: WO2005/58871 A1, 2005 ; Location in patent: Page/Page column 42-43 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |